LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial | MicrobiomeTrials← Back to trialsNCT07645300
LOw DosE Spironolactone, chlorThAlidone oR Combination in CKD Trial
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-10-01Est. Completion: 2032-03-31
Enrollment target: 160 participants Locations- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis, Indiana, United States
Other microbiome trials you might be interested in
Severe Preeclampsia
This randomized, double-blind, placebo-controlled trial evaluates whether oral furosemide 40 mg, initiated 12 hours post…
Tegucigalpa, HondurasEst. completion Dec 31, 2026
HypertensionMedication AdherenceBehavior and Behavior Mechanisms
Randomized controlled trial testing the efficacy of the Supporting Tailored Adaptive change and Reinforcement for Medica…
Baton Rouge, United StatesEst. completion Apr 30, 2027